Abstract
Since January 1977, polytetrafluoroethylene (PTFE)-Goretex has been used 82 times as aortoiliac substitute: 49 ilio-femoral, 17 ilio-profundal, 10 axillo-femoral, and 6 femoro-femoral cross-over bypasses were performed. In this group of patients 20% were diabetics, 85% were in a preoperative Stage III or IV according to Fontaine, with an average age of 66 years. Postoperative anticoagulation therapy was not used routinely. Each patient had noninva sive diagnostic procedures pre- and postoperatively (Figure 1).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
